Inhibitory Antibodies
-
F1439 Anti-NaPi2b/SLC34A2 Antibody (Lifastuzumab vedotin)Summary: Anti-NaPi2b/SLC34A2 Antibody (Lifastuzumab vedotin) -
F1440 Anti-ENTPD1/CD39 Antibody (TTX-030)Summary: Anti-ENTPD1/CD39 Antibody (TTX-030) -
F1441 Anti-Siglec-3/CD33 Antibody (Gemtuzumab-CLM)Summary: Anti-Siglec-3/CD33 Antibody (Gemtuzumab-CLM) -
F1442 Anti-ANO1/TMEM16A Antibody (Novartis patent anti-TMEM16A )Summary: Anti-ANO1/TMEM16A Antibody (Novartis patent anti-TMEM16A ) -
F1443 Anti-SLC40A1 Antibody (LY2928057)Summary: Anti-SLC40A1 Antibody (LY2928057) -
F1444 Anti-NaPi2b/SLC34A2 Antibody (Lifastuzumab)Summary: Anti-NaPi2b/SLC34A2 Antibody (Lifastuzumab) -
F1445 Anti-NaPi2b/SLC34A2 Antibody (Upifitamab)Summary: Anti-NaPi2b/SLC34A2 Antibody (Upifitamab) -
F1446 Anti-ANGPTL3 Antibody (Evinacumab)Summary: Anti-ANGPTL3 Antibody (Evinacumab) -
F1447 Anti-CA9/CAIX Antibody (Girentuximab)Summary: Anti-CA9/CAIX Antibody (Girentuximab) -
F1448 Anti-F11/Factor XI Antibody (Abelacimab)Summary: Anti-F11/Factor XI Antibody (Abelacimab)